F M Marincola

The nude mouse as a model for the study of human pancreatic cancer.

W D Holder, F. Marincola, F M Marincola, 1989, The Journal of surgical research.

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

A Sette, F. Marincola, A. Sette, 1995, Journal of immunology.

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.

F. Marincola, S. Rosenberg, P. Hwu, 1998, Journal of the National Cancer Institute.

Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

F. Marincola, S. Rosenberg, J. Mulé, 1994, Journal of immunology.

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.

S Ferrone, F. Marincola, D. Hicklin, 1999, Molecular medicine today.

Advantages of mRNA amplification for microarray analysis.

S K Libutti, F. Marincola, A. Feldman, 2002, BioTechniques.